Does Previous Anti-thrombotic Use Affect the Course of Coronavirus Disease-2019?

This publication has 27 references indexed in Scilit:

• Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
  Clinica Chimica Acta, 2020
• Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
  Clinica Chimica Acta, 2020
• Clinical Characteristics of Coronavirus Disease 2019 in China
  New England Journal of Medicine, 2020
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
  JAMA, 2020
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
  Cell, 2020
• Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
  Journal of Thrombosis and Haemostasis, 2020
• Prevention or Treatment of Ards With Aspirin
  Shock, 2017
• Proteinase-activated receptors in fibroproliferative lung disease
  Thorax, 2013
• The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome
  BMC Medicine, 2013
• Antithrombotic Drugs: Pharmacology and Implications for Dental Practice
  Anesthesia Progress, 2013